Court Orders Settlement Discussions Between LifeCell and TelaBio Confidential

July 29, 2016 – The Court ordered the upcoming settlement discussions between Plaintiff LifeCell Corporation and Defendant TelaBio, Inc. to be kept confidential pursuant to Federal Rule of Evidence 408, and requested immediate notification of any illegal threats. The patent-at-issue is U.S. Patent No. 6,143,293 which relates to a three-dimensional scaffold for tissue generation. The case is Civil Action No. 16-4158 in the United States District Court for the District of New Jersey.

By: Katherine E. Adams

View Attachment (PDF)